Rice University secured up to $24.8 million from ARPA‑H to advance bioprinted kidney tissue under the PRINT program, funding a multi‑year effort to develop transplantable, vascularized renal constructs. Led by Dr. Antonios Mikos, the project aims to address organ shortages by engineering kidney tissues with the structural and functional complexity required for clinical translation. ARPA‑H’s investment reflects growing federal support for bioengineering solutions to organ failure. The award accelerates efforts to translate bioprinting from preclinical models to scalable manufacturing pathways and will test technologies for vascular integration and long‑term graft function.